C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2403937
A method of designing human clinical drug trials in which the drug under study is administered to a defined population of test patients who have demonstrated a predisposition to responding to the study drug by virtue of their having one or more genes that have independently been determined to be associated with the desired response.
La présente invention concerne un procédé permettant de concevoir des essais cliniques de médicaments chez l'homme, essais pour lesquels le médicament à l'étude est administré à une population définie de patients tests qui ont fait preuve d'une prédisposition à réagir au médicament étudié du fait qu'ils sont porteurs d'au moins un gène dont chacun s'est avéré associé à la réaction attendue.
Glaxo Group Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Iterative analysis of non-responding population in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iterative analysis of non-responding population in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iterative analysis of non-responding population in the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2081193